CD79A and arthritic joint disease: This effect has been shown on a clinical scale, with infusion of pooled human serum IgA reducing inflammation in synovial infiltrates in rheumatoid arthritis as well as reducing symptoms of arthritis in human FcαR transgenic mice [64].